```html

Physiologic Jaundice of the Newborn – A Complete Medical Guide

Overview

Physiologic jaundice is the most common type of newborn jaundice, affecting approximately 60 % of term infants and up to 80 % of pre‑term infants in the first week of life [Mayo Clinic]. It results from a temporary buildup of bilirubin—a yellow pigment produced when red blood cells break down. In most cases, physiologic jaundice is harmless and resolves without treatment, but careful monitoring is essential to avoid progression to more serious forms of hyperbilirubinemia.

Symptoms

The hallmark of newborn jaundice is a yellow discoloration of the skin and sclera (the whites of the eyes). The pattern of discoloration often gives clues about severity.

Typical presentation

• Skin: Yellowing usually begins on the face and progresses down the chest, abdomen, and then the limbs. It may be more noticeable on the trunk because the skin of newborns is thin.
• Eyes (scleral icterus): Yellowing of the whites of the eyes often appears before the skin becomes noticeably yellow.
• Timing: Onset typically occurs between 24–72 hours after birth in term infants; in pre‑term infants, it may appear later, up to 5 days.
• Feeding changes: Slight decrease in feeding frequency or a brief period of lethargy may accompany higher bilirubin levels.

Less common but important signs

• Dark urine (bilirubin excreted via urine)
• Pale stools (reduced bilirubin excretion in the gut)
• Unusual sleepiness or poor sucking reflex in severe cases

Causes and Risk Factors

Physiologic jaundice arises from the normal newborn transition from fetal to post‑natal life. The main mechanisms include:

• Increased bilirubin production: Fetal red blood cells have a shorter lifespan. After birth, the breakdown of these cells releases large amounts of unconjugated bilirubin.
• Immature liver enzyme system: The enzyme UDP‑glucuronosyltransferase (UGT1A1), which converts unconjugated bilirubin into water‑soluble conjugated bilirubin, is under‑developed in newborns and reaches adult activity around 2 weeks of age.
• Reduced enterohepatic circulation: In the first days of life, intestinal bacteria that convert bilirubin back into its absorbable form are sparse, leading to re‑absorption of bilirubin.

Risk factors that increase the likelihood or severity

• Prematurity (<37 weeks gestation)
• Breastfeeding difficulties or delayed feeding (dehydration reduces bilirubin excretion)
• Maternal diabetes, especially if the infant is large‑for‑gestational‑age
• Blood type incompatibility (e.g., ABO or Rh) that can cause hemolysis—though this may shift the cause toward pathological jaundice, it can exacerbate physiologic jaundice.
• Bruising or birth trauma leading to increased red‑cell breakdown
• Sibling with severe neonatal jaundice (genetic predisposition to lower UGT1A1 activity)

Diagnosis

Diagnosis is primarily clinical, supported by quantitative bilirubin measurement.

Physical examination

• Visual assessment of skin and sclera for icterus.
• Determine the “cephalocaudal” spread (head‑to‑toe) – a useful bedside indicator of bilirubin level.

Laboratory tests

• Serum total bilirubin (TSB): Obtained via a heel‑stick or venous sample. Levels are plotted on an age‑specific nomogram (the “Bhutani” or “Phototherapy” chart) to classify risk.
• Direct (conjugated) bilirubin: A value <2 mg/dL suggests the jaundice is primarily unconjugated, consistent with physiologic jaundice.
• Blood type and Coombs test: Performed when hemolytic disease is suspected.
• Complete blood count (CBC): To assess for anemia or hemolysis.

Additional assessments (used selectively)

• G6PD deficiency screening in populations where it is common.
• Thyroid function tests if prolonged jaundice (>3 weeks) is observed.

Treatment Options

Most cases of physiologic jaundice require only supportive care. Treatment is guided by the infant’s age in hours and the measured bilirubin level.

Phototherapy

• Indicated when bilirubin exceeds risk‑based thresholds (e.g., > 12 mg/dL at 48 hours in term infants).
• Uses blue‑light (≈460 nm) to convert bilirubin into water‑soluble isomers that can be excreted without liver conjugation.
• Devices:
  • Conventional overhead or blanket phototherapy units.
  • LED phototherapy – more efficient and generates less heat.
• Typical duration: 12–24 hours, with bilirubin re‑checked every 4–6 hours.

Exchange transfusion

Rarely needed for physiologic jaundice, but reserved for extreme hyperbilirubinemia (>25 mg/dL) or rapid rise despite optimal phototherapy.

Feeding and hydration

• Frequent breastfeeding (8–12 times/day) or formula supplementation if intake is inadequate.
• Breast‑milk jaundice (different from physiologic jaundice) may require temporary formula supplementation, but this is usually not required for physiologic jaundice.

Medications

There are no specific drugs for physiologic jaundice. Phenobarbital has been studied to induce UGT1A1 activity but is not routinely recommended due to side‑effects.

Living with Jaundice of Newborn (Physiologic)

Parents can play a crucial role in monitoring and supporting their baby.

Daily management tips

• Feeding schedule: Aim for at least 8‑12 feeds per day. Watch for wet diapers (≥6/day) and stool frequency (≥3/day).
• Skin checks: Examine the baby’s skin and eyes every 4–6 hours. Note any progression of yellowing.
• Lighting: Keep the baby under normal ambient light; do not cover the infant with blankets during phototherapy unless instructed.
• Temperature: Maintain a neutral thermal environment (room temperature 72‑74 °F). Over‑heating can worsen bilirubin levels.
• Follow‑up: Most hospitals discharge infants after a stable bilirubin reading and adequate feeding. Ensure the first outpatient visit occurs within 48‑72 hours of discharge.

When to call the pediatrician

• Feeding difficulties lasting >12 hours.
• Decrease in wet diapers or stools.
• Rapid spread of jaundice to the abdomen or legs.
• Any change in the baby’s alertness, tone, or temperature.

Prevention

While physiologic jaundice cannot be completely prevented, several strategies can lower its severity.

• Early and frequent feeding: Initiate breastfeeding within the first hour after birth and continue with regular intervals.
• Monitor maternal conditions: Good glycemic control in diabetic mothers reduces risk.
• Avoid unnecessary formula supplementation: Only use formula when breastfeeding is ineffective, as exclusive breastfeeding supports bilirubin elimination through stool.
• Educate caregivers: Teach families how to recognize early signs of jaundice before discharge.

Complications

When left unchecked, high levels of unconjugated bilirubin can cross the immature blood‑brain barrier, leading to kernicterus.

Potential complications

• Kernicterus (bilirubin‑induced neurologic dysfunction): Permanent brain injury causing hearing loss, movement disorders, and cognitive deficits.
• Acute bilirubin encephalopathy: Reversible early neurologic signs (lethargy, high‑pitch cry, poor feeding).
• Very low birth weight outcomes: In pre‑term infants, severe hyperbilirubinemia is associated with increased mortality.

According to the WHO, severe neonatal jaundice accounts for an estimated 1.1 million cases of acute bilirubin encephalopathy worldwide each year, emphasizing the importance of early detection [WHO, 2022].

When to Seek Emergency Care

References

• Mayo Clinic. “Newborn Jaundice.” https://www.mayoclinic.org/diseases-conditions/newborn-jaundice/symptoms-causes/syc-20373838 (accessed May 2026).
• American Academy of Pediatrics. “Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.” Pediatrics, 2022.
• World Health Organization. “Neonatal Jaundice Fact Sheet.” 2022. https://www.who.int/news-room/fact-sheets/detail/neonatal-jaundice
• National Institute of Child Health and Human Development. “Bilirubin and Jaundice in the Newborn.” https://www.nichd.nih.gov/health/topics/jaundice
• Cleveland Clinic. “Physiologic Jaundice in Newborns.” https://my.clevelandclinic.org/health/diseases/17631-newborn-jaundice

```